Elite in Brachydactyly Type A2

Jie X. Ma

No.110 Ganhe Road, 
Shanghai, CN 
Elite in Brachydactyly Type A2
No.110 Ganhe Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Jie Ma practices in Shanghai, China. Ma is rated as an Elite expert by MediFind in the treatment of Brachydactyly Type A2. Their top areas of expertise are Brachydactyly Type A2, Lung Cancer, Brachydactyly, Mastectomy, and Pancreaticoduodenectomy.

Their clinical research consists of co-authoring 2187 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Brachydactyly Type A2.

Locations

No.110 Ganhe Road, Shanghai, 200437, China
Other Locations
1239 Siping Road, Shanghai, 200092, China
6 Shuangyong Road, Nanning, 530021, China
Pokfulam Road, Hong Kong, China
222 Tianshui South Road, Lanzhou, 730000, China
28 Fuxing Road, Haidian, 100853, China
No. 139 Middle Renmin Road, Changsha, 410011, China
NO. 1200, Cailun Road, Shanghai, 201203, China
Shenzhen Branch, Shenzhen, China
Siping Road, Shanghai, 200092, China
Peking Union Medical College Hospital, Beijing, 100010, China
No 127, Dongming Road, Zhengzhou, 450008, China
No. 3, East Street, Yongding Road, Haidian, 100039, China
No. 1 Xinmin Road, Changchun, 130021, China
No. 100 Kexue Road, Zhengzhou, 450001, China
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China
Department Of Peptide Drugs R&D, Shanghai, China
28 West Xianning Street, Xi'an, 710000, China
219 Miaopu Road, Shanghai, 200135, China
No.1, East Jianshe Road, Zhengzhou, 450052, China
No. 30 Science Park Road, Zhong Guan Cun Life Science Park, Changping, 102206, China
100 Hai Quan Road, Shanghai, 201418, China
Yangtze River Fisheries Research Institute, Wuhan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Study Phase: Phase 3
A Multicenter, Open-label, Single-arm, Phase II Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
A Multicenter, Open-label, Single-arm, Phase II Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Enrollment Status: Terminated
Publish Date: February 23, 2024
Intervention Type: Drug
Study Drug: Mitoxantrone Hydrochloride
Study Phase: Phase 2
An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib SandwichWith Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma
An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib SandwichWith Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug
Study Drug: Sintilimab
Study Phase: Phase 2
View 2 Less Clinical Trials

2187 Total Publications

Fingerprinting of dissolved constituents in groundwater at an operating refinery.
Fingerprinting of dissolved constituents in groundwater at an operating refinery.
Journal: Environmental science. Processes & impacts
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ma's expertise for a condition
ConditionClose
View All 48 Advanced Conditions
View All 231 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile